Validation of bioanalytical assays and IND- enabling GLP PD/PK toxicology studies in rats and dogs
Active Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,553,595
Award facts
- Opportunity
-
- 75N95024R00034 Solicitation number
- Contract value 11% obligated
-
- $1,553,595.00 Current, with exercised options
- $14,106,772.00 Potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $835,623 | |
| Original award | $717,972 |
About this award
This is a $14,106,772 cost plus fixed fee delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Battelle Memorial Institute for validation of bioanalytical assays and IND-enabling GLP PD/PK toxicology studies in rats and dogs. The work is being performed under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite delivery, indefinite quantity (IDIQ) contract. No set-aside was used for this award, and the period of performance runs through March 10, 2027. Battelle is a non-profit organization and manufacturer of goods that frequently supports U.S. federal agencies through research, engineering, testing, and technical services.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on March 11, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $1,553,595 on 75N95024F00001. Its potential value, with all options, is $14,106,772.
Which agency awarded contract 75N95024F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95022D00021, an indefinite delivery contract, on Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award